HEALTHCBS NEWS
Safety concerns over doctors prescribing experimental weight loss drug not approved by FDA
Doctors are prescribing an experimental weight loss drug called retatrutide that has not been approved by the FDA, raising safety concerns. The treatment is currently under evaluation and not yet authorized for use.
Related Signal
Adjacent reporting
- Doctors prescribing weight loss drug not yet approved by FDA, CBS News investigation finds
- How an experimental weight-loss drug is being openly promoted by physicians
- STAT+: Lilly’s ‘triple-G’ drug leads to bariatric-surgery levels of weight loss in trial
- FDA asks Lilly for more safety data on weight loss pill Foundayo
- New Weight Loss Drug Retatrutide Delivers Stunning Results